Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients
Launched by JUNYAN ZHAO · Dec 1, 2022
Trial Information
Current as of January 17, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cancer patients undergoing chemotherapy throughout their treatment in our hospital
- • Patients with PICC implanted for the first time and maintained at our hospital;
- • Age 18-60 years;
- • Normal cognitive function;
- • the clenching movement is barrier-free;
- • The material and performance of PICC catheter are silicone three-way valve catheter;
- • Catheter placement under the guidance of portable color Doppler ultrasound diagnostic instrument;
- • Voluntarily participate and sign the informed consent form.
- Exclusion Criteria:
- • Patients treated with combined radiotherapy;
- • Patients with coagulation dysfunction;
- • Patients who need to use anticoagulant drugs due to underlying diseases;
- • Puncture times more than 1 time;
- • The blood flow velocity of catheterization vessel in calm state was less than 4.78cm/s.
Trial Officials
Junyan Zhao, Master
Study Director
Qianfoshan Hospital
Yuanjing Qiao, Master
Principal Investigator
Shandong University of Traditional Chinese Medicine
About Junyan Zhao
Junyan Zhao is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, Junyan Zhao leads initiatives that emphasize rigorous scientific methodology, ethical standards, and collaborative partnerships within the healthcare community. By fostering an environment of transparency and integrity, Junyan Zhao aims to accelerate the development of effective treatments while prioritizing patient safety and well-being throughout the clinical trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jinan, Shandong, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials